6/12/2023 0 Comments Michael klammerWhen you hear on the news all of the stories about climate changes and oceans rising and bird flus and other pandemics, and I know we’re in an era of fear-mongering with the 24/7 news cycle. “And I think we’re at a time like that, too. “I think Thonton Wilder was looking at our past and seeing that the human race gets through by the skin of our teeth,” Smith said. The Nazis were still in Germany and had Europe under its thumb, while the Japanese controlled the Pacific arena. In the play, George and Maggie Antrobus their two children, Gladys and Henry and maid Sabina overcome ice, flood and war-by the skin of their teeth.ĭirector Virginia Smith noted that when the play premiered in 1942, World War II was still ongoing. in Howell Theatre, located on the first floor of the Temple Building at 12th and R sts. Performances are March 5-7 and 11-14 at 7:30 p.m. The University Theatre season continues this March with Thornton Wilder’s “The Skin of Our Teeth.” Michael is also very involved with a number of Los Angeles food banks and charities that feed the homeless.Emma Gruhl (top) and Kayla Klammer rehearse a scene from "The Skin of Our Teeth," which opens March 5. Michael enjoys managing the family business (four adult children!), losing golf balls and chasing his run away Airedale terrier. Michael has an MBA in Finance from The Wharton School and a BA from the University of California at San Diego. He began his health care career as a hospital consultant for American Medical International (now Tenet Health Care). Inc., Michael was a Vice President in the health care investment banking group and completed in excess of $2.0 billion of transactions for large multi-hospital systems, academic health centers, financially distressed institutions and long-term care facilities. He sold Pharm Plus to US Bioservices, an Amerisource Bergen affiliate.Īt Dillon, Read & Co. The company initially targeted the HIV/AIDS market and expanded its product line to include oncology, growth hormone, hemophilia and specialty injectable’s. He was instrumental in developing and managing the company’s international heparin and biologics businesses and was involved in the acquisition of numerous health care, biotechnology, pharmaceutical manufacturing, real estate and data center assets.Īs a health care entrepreneur, Michael founded Pharm Plus Resources, a southern California distributor of specialty pharmaceuticals and intravenous medications, including providing highly skilled nursing services. He completed numerous transactions with Watson Pharmaceuticals, Valeant Pharmaceuticals and Pfizer on behalf of the company. Prior to joining Diamond, Michael held the position of Vice President for Acquisitions and Development for Nantworks and its formerly affiliated companies – Celgene, Abraxis Bioscience, American Bioscience and American Pharmaceutical Partners. Michael’s entire career has been focused on the health care sector as an investment banker, entrepreneur and mergers and acquisitions specialist for private and publicly traded pharmaceutical and biotechnology companies. Brunelle is a Managing Director of Diamond Capital Advisors and specializes in health care and biotechnology companies.
0 Comments
Leave a Reply. |